Severe COVID-19 in Patients with B Cell Alymphocytosis and Response to Convalescent Plasma Therapy

J Clin Immunol. 2021 Feb;41(2):356-361. doi: 10.1007/s10875-020-00904-5. Epub 2020 Nov 20.

Jonathan London¹, David Boutboul^{2

3}, Karine Lacombe⁴, France Pirenne⁵, Beate Heym⁶, Valérie Zeller⁷, Antoine Baudet⁸, Amani Ouedrani^{9

10}, Alice Bérezné⁸

¹ Department of Internal Medicine and Infectious diseases, Hôpital Diaconesses Croix Saint-Simon, 125 rue d'Avron, 75020, Paris, France. jlondon@hopital-dcss.org.
² Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris (APHP), Université de Paris, Paris, France. david.boutboul@aphp.fr.
³ U976 HIPI, Insight team, Hôpital Saint-Louis, Université de Paris, Paris, France. david.boutboul@aphp.fr.
⁴ Department of Infectious Diseases, Hôpital Saint-Antoine, Assistance Publique Hôpitaux de Paris (APHP), Université de Paris, Paris, France.
⁵ Établissement Français du Sang, INSERM-U955, University Paris-Est-Créteil, Créteil, France.
⁶ Department of Microbiology, Hôpital Diaconesses Croix Saint-Simon, Paris, France.
⁷ Department of Internal Medicine and Infectious diseases, Hôpital Diaconesses Croix Saint-Simon, 125 rue d'Avron, 75020, Paris, France.
⁸ Department of Internal Medicine, CHR Annecy-Genevois, Annecy, France.
⁹ CNRS UMR8253, INSERM UMR1151, Institut Necker-Enfants Malades, Université de Paris, Paris, France.
¹⁰ Laboratory of Immunology, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France.

No abstract available

Publication types